There were two distinct types of cancer cells, one with high expression of BRM (e.g., non-small cell lung cancer A549 and NCI-H1299, breast ductal cancer MDA-MB435, cervical cancer HelaS3, and oral cancer KB) while the other with very low levels of BRM (e.g., adrenocortical cancer SW13, gastric cancer AZ521, non-small cell lung cancer NCI-H522, cervical cancer C33A, and embryonic cancer cells PA-1). This evidence concerns the gene SMARCA2 and cervical cancer.